Central Mechanisms in Speech Motor Control Studied With H215O PET
NCT ID: NCT00001308
Last Updated: 2019-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
1163 participants
OBSERVATIONAL
1992-04-28
2016-10-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Most of the PET scan studies conducted have concentrated on learning about how language is formed and decoded. Few studies have been conducted on speech production. This study aims to use radioactive water (H215O) and Positron Emission Tomography (PET scan) to measure blood flow to different areas of the brain in order to better understand the mechanisms involved in speech motor control.
When a region of the brain is active, it uses more fuel in the form of oxygen and sugar (glucose). As the brain uses more fuel it produces more waste products, carbon dioxide and water. Blood carries fuel to the brain and waste products away from the brain. As brain activity increases blood flow to and from the area of activity increases also. Knowing these facts, researchers can use radioactive chemicals (H215O) and PET scans to observe what areas of the brain are receiving more blood flow.
Researchers will ask patients to perform tasks that will affect speech, voice, and language. At the same time patients will undergo a PET scan. The tasks are designed to help researchers observe the blood flow to brain areas associated with voicebox (laryngeal) functions, movement of muscles in the jaw, tongue, and mouth, and other aspects of motor speech.
Special studies will be conducted to evaluate how certain therapies and tasks can draw out symptoms in illnesses in which speech and language are affected. Results of these tests will be used in other studies to evaluate the neurologic mechanisms of diseases like Tourette's syndrome and parkinson's disease.\<TAB\>
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary objective of this protocol is to use multimodal neuroimaging combining complementary electrophysiological and hemodynamic methods to characterize brain-language relationships in healthy subjects and those with neurological disorders that affect speech and language. A secondary objective is to utilize these findings to develop evaluation measures for future treatment studies.
Study Populations
We will focus on four neurological disorders that affect language processing post-stroke aphasia, traumatic brain injury, epilepsy and developmental stuttering. Each constitutes a significant clinical problem central to the NIDCD s mission. These disorders can impair language at several levels - from its elementary perceptual and motor features, the peripheral building blocks of language, to higher levels of language formulation, including word, sentence and narrative processing.
Design
We will utilize a set of tasks designed to evaluate language at the levels at which clinical pathology emerges. We will combine hemodynamic (functional MRI) and electrophysiological (EEG, MEG) modalities to capitalize on the superior spatial resolution of the former and temporal resolution of the latter methods. Whenever possible the same task paradigms are used with both techniques. We will conduct crosssectional sub-studies, addressing specific questions in each of the disorders of interest; we will also conduct longitudinal sub-studies of recovery and neuroplastic reorganization in post-stroke aphasia.
Outcome Measures
Outcome measures include speech-language and psychological tests, measures of behavioral performance during scanning and corresponding MRI, EEG and MEG data. Relationships between these datasets will be evaluated using statistical analytic packages.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Ability to provide informed consent.
Must be a Native English speaker by age 2
Have had training and experience in creative writing
Have had training and experience in vocal or instrumental music
Have had training and experience in visual arts
Had sensorimotor and language deficits following ischemic infarcts.
Had stroke at least two weeks ago.
Diagnosis of TBI
At least one month post-injury
History of developmental stuttering with symptoms of dysfluency presenting before the age of 13
If recovered, history documented by school or medical records.
Ages 18 to 55 years.
Failure of seizures to respond to adequate therapy with at least two standard antiepileptic drugs.
Willingness to be considered for surgery
Fluency in English. Non-native speakers may be included if their fluency is equivalent to that of a native speaker.
Must have localization-related epilepsy
Must be currently enrolled in Protocol 08-N-0161 to participate in this study
Exclusion Criteria
Significant abnormalities on the general physical examination unrelated to the stroke or TBI
Unable to undergo MRI studies due to pacemakers, aneurysm clips, cochlear implants, shrapnel fragments or a significant history of exposure to small metallic objects which might have become lodged in the tissues of the head or neck or who require hearing aids.
Subjects who are pregnant are excluded from the PET and MRI tests in this study.
Subjects who are lactating are excluded from the PET tests.
Subjects who have or are found to have significant visual agnosia.
Subjects who cannot provide informed consent.
More than two prior strokes
Concurrent diagnoses of neurodegenerative disorders or vascular dementia
Comprehension Aphasia Quotient (AQ) of less than 4 on the Western Aphasia Battery (WAB)
For military subjects: Positive screen for Acinetobacter baumannii-calcoaceticus complex (ABC) infection or colonization
Severe cognitive impairments as evidenced by scores of less than 7 on the Rancho Los Amigos Scale of Cognitive Functioning and/or less than 76 on the Galveston Orientation and Amnesia Test.
For all subjects: Comprehension AQ of less than 4 on the WAB
A diagnosis of PTSD, which is almost always found in TBI subjects recruited from the military, will not disquality TBI subjects from participation.
Structural abnormalities on standard clinical (MPRAGE, T2-weighted) MRI scans studies
A diagnosis of anxiety dirorder will not disqualify stuttering subjects from participation
Claustrophobia or anxiety disorders that could be exacerbated by the MRI Scanner
Subjects with neurological disorders, in addition to epilepsy such as, stroke, Parkinson s disease), or who have psychiatric diagnoses (, such as, obsessive-compulsive disorder)
Patients on Phenobarbital or chronic Benxodiazepines
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Deafness and Other Communication Disorders (NIDCD)
NIH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Allen R Braun, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Institute on Deafness and Other Communication Disorders (NIDCD)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357-81. doi: 10.1146/annurev.ne.09.030186.002041. No abstract available.
Andrews G, Quinn PT, Sorby WA. Stuttering: an investigation into cerebral dominance for speech. J Neurol Neurosurg Psychiatry. 1972 Jun;35(3):414-8. doi: 10.1136/jnnp.35.3.414.
Bartlett EJ, Brown JW, Wolf AP, Brodie JD. Correlations between glucose metabolic rates in brain regions of healthy male adults at rest and during language stimulation. Brain Lang. 1987 Sep;32(1):1-18. doi: 10.1016/0093-934x(87)90115-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
92-DC-0178
Identifier Type: -
Identifier Source: secondary_id
920178
Identifier Type: -
Identifier Source: org_study_id